Li, X., & Song, Y. (2020). Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy. Journal of hematology and oncology, 13(1), 50-14. https://doi.org/10.1186/s13045-020-00885-3
Chicago Style (17th ed.) CitationLi, Xin, and Yongcheng Song. "Proteolysis-targeting Chimera (PROTAC) for Targeted Protein Degradation and Cancer Therapy." Journal of Hematology and Oncology 13, no. 1 (2020): 50-14. https://doi.org/10.1186/s13045-020-00885-3.
MLA (9th ed.) CitationLi, Xin, and Yongcheng Song. "Proteolysis-targeting Chimera (PROTAC) for Targeted Protein Degradation and Cancer Therapy." Journal of Hematology and Oncology, vol. 13, no. 1, 2020, pp. 50-14, https://doi.org/10.1186/s13045-020-00885-3.
Warning: These citations may not always be 100% accurate.